Kyverna Therapeutics Inc. (KYTX)
NASDAQ: KYTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 6.17 0.00%
KYTX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $381.57M
- EPS (TTM)
- -$2.93
- Dividend yield
- None
- 52-week range
- 5.94 – 13.67
- Day range
- 6.05 – 6.31
- Volume / Avg
- 650.28K / 907.11K
- Beta
- —
- Shares outstanding
- 61.84M
- Next earnings
- Nov 11, 2026
52-week range
KYTX stock today
Shares of Kyverna Therapeutics (KYTX) finished higher on Oct 7 at $6.17, a gain of 0.16% or $0.01 per share, versus the S&P 500's 0.22% decline. At this level, KYTX sits near the bottom of its 52-week range of $5.94 to $13.67: 54.9% below the high, set on Dec 15, 2025 and 4.0% above the low. KYTX is down 34.4% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 14.0%.
Kyverna Therapeutics has posted a net loss over the last twelve months (EPS of -$2.93), so its P/E ratio is not meaningful. Kyverna Therapeutics's next earnings report is expected on Nov 11, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Kyverna Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year
- 2024
Earnings
Earnings history- Next report
- Nov 11, 2026
Kyverna Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| FENCFennec Pharmaceuticals Inc. | 10.36 | +0.10% | $363.30M | vs KYTX |
| ZURAZura Bio Limited Class A | 4.17 | +5.30% | $399.61M | vs KYTX |
| EIKNEikon Therapeutics Inc. | 7.54 | +0.40% | $408.40M | vs KYTX |
| CCCCC4 Therapeutics Inc. | 2.82 | -2.08% | $346.93M | vs KYTX |
| ARTVArtiva Biotherapeutics Inc. | 7.00 | -3.71% | $342.23M | vs KYTX |
| AGENAgenus Inc. | 7.57 | +1.07% | $341.88M | vs KYTX |
| EDITEditas Medicine Inc. | 2.75 | +0.73% | $422.35M | vs KYTX |
| OCGNOcugen Inc. | 1.00 | -3.85% | $339.11M | vs KYTX |
Indexes, lists and sector
Kyverna Therapeutics stock FAQ
What is Kyverna Therapeutics's stock price today?
KYTX last traded at $6.17 as of Oct 7, 4:00 PM EDT, up 0.16% on the day. Prices are delayed at least 15 minutes.
When is Kyverna Therapeutics's next earnings date?
Kyverna Therapeutics is expected to report earnings on Wednesday, November 11, 2026.
What is the KYTX 52-week high?
The 52-week high for KYTX is $13.67 and the 52-week low is $5.94. The stock is currently 54.9% below its high.